- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03040609
Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision) (PLH-Vision)
The main objective of this study is to develop and validate a visio-behavioral scale of visual abilities for subjects with profound multiple intellectual disabilities.
The secondary objectives of the study are:
- to validate the structure of the scale.
- to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners.
- to evaluate the feasibility of visio-behavioral scale.
- to evaluate the sensitivity to change.
- to study the uniformity of use of the scale depending on the type of patients (age, disability level, pathology).
- to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.
Visão geral do estudo
Status
Descrição detalhada
This study includes 3 phases:
- Elaboration of a list of behavioral items by a group of multi-disciplinary expertise (physicians, nurses, caregivers, ophthalmologies, orthoptists) based on their clinical experiences.
- Development of the scale based on the sample obtained by a prospective multicenter research trial.
- Validation of the sample obtained by a prospective transversal multicenter study.
This study will be performed in 5 centers in France. The enrollment of patients planned for 24 months targeting 310 patients. The duration of follow-up of the study for each patient will be varied according to the group of patients, il will be 1 day for group 1, 2 weeks for group 2, or 6 months for group 3.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
Var
-
Hyères, Var, França, 83407
- Hôpital San Salvadour
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Causal brain injury occurred before the age of 3 years.
- Severe or deep mental retardation as defined by DSM IV.
- Motor impairment: para / tetraparesis, hemiparesis, ataxia, or extrapyramidal motor disorders.
- Score of Gross Motor Function Classification System [Palisano 1997] is III, IV or V.
- Score of Functional Independence Measure < 55.
- Subject aged ≥3 years (because the visio-behavioral scale is not adapted for children younger than 3 years).
- Beneficiary of a social protection.
- Written consent signed by guardian or legal representative, or parents in case of a minor subject.
Exclusion Criteria:
- Acute intercurrent pathology precluding examinations.
- Patient with hypersensitivity to tropicamide, atropine or benzalkonium chloride.
- Angle closure glaucoma suspect patient.
- Patient with severe hypertension.
- Short life expectancy.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: Coorte
- Perspectivas de Tempo: Prospectivo
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
---|---|
Group 1
The duration of follow-up of group 1 in the study is 1 day.
|
To perform the classification with the scale by caregiver.
To perform the classification with the scale by orthoptist at the end of 2 weeks
To perform the classification with the scale by orthoptist at the end 6 months.
|
Group 2
The duration of follow-up of group 2 in the study is 2 weeks.
|
To perform the classification with the scale by orthoptist at the end of 2 weeks
To perform the classification with the scale by orthoptist at the end 6 months.
|
Group 3
The duration of follow-up of group 3 in the study is 6 months.
|
To perform the classification with the scale by orthoptist at the end 6 months.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Concordance of classification
Prazo: throughout the study: 31 months
|
Statistical analysis: concordance between the classification obtained by caregiver with the scale, and the classification obtained by orthoptist-ophthalmology.
|
throughout the study: 31 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Structure of the scale
Prazo: throughout the study: 31 months
|
Statistical analysis to validate the structure of the scale.
|
throughout the study: 31 months
|
Reproducibility of scale
Prazo: throughout the study: 31 months
|
Statistical analysis to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners.
|
throughout the study: 31 months
|
Feasibility of visio-behavioral scale
Prazo: throughout the study: 31 months
|
Statistical analysis to evaluate by the proportion of patients who have the complet examination, the average of time to all examens, the tolerance data. feasibility of visio-behavioral scale. |
throughout the study: 31 months
|
Sensitivity to change
Prazo: throughout the study: 31 months
|
Statistical analysis to evaluate the sensitivity to change.
|
throughout the study: 31 months
|
Uniformity of use of the scale
Prazo: throughout the study: 31 months
|
Statistical analysis to assess the uniformity of use of the scale depending on the type of patients (age, disability level, pathology).
|
throughout the study: 31 months
|
Prevalence of the visual disorder
Prazo: throughout the study: 31 months
|
Statistical analysis to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.
|
throughout the study: 31 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Marie-Christine ROUSSEAU, MD, AP-HP, Hôpital San Salvadour, 83407 Hyères
- Cadeira de estudo: Soizic CHARBONNIER, Orthoptist, Cabinet du Lycée
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- P140712
- RCB: 2016-A00278-43 (Outro identificador: ANSM)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .